A month has gone by since the last earnings report for Kymera Therapeutics, Inc. (KYMR) . Shares have added about 10.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Kymera Therapeutics due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Kymera Q2 Loss Narrower Than ...